is glp 1 a drug GLP-1 Drugs from the Gray Market GLP-1 Drugs Cut Risk of

Another randomized controlled clinical trial specifically focusing on their weight loss effects demonstrated that, in adults with overweight or obesity without diabetes, once-weekly subcutaneous injection of semaglutide resulted in significantly greater weight loss at 68 weeks compared with once-daily subcutaneous injection of liraglutide, and the incidence of gastrointestinal adverse reactions was similar between the two groups [Reference Rubino, Greenway, Khalid, ONeil, Rosenstock and Srrig47]

Hill CJ, Fogarty DG

Clinical trials consistently demonstrate that patients using Ozempic achieve greater weight loss outcomes compared to those relying solely on lifestyle modifications or other weight-loss medications

Scarpa M, Rigo A, Maiorino M, Ursini F